Akcea therapeutics stock
Oct 07, 2019 · Akcea Therapeutics (AKCA) stock is flying high on Monday following news of a $250 million deal with Pfizer (NYSE:PFE) for licensing rights. Media & Investors | Akcea Therapeutics Akcea Therapeutics is a development and commercialization company focused on helping patients living with serious and rare diseases. Our priority is to bring transformative medicines to patients by driving clinical program execution, understanding patient and physician needs, preparing the market, creating market access, and commercializing our AKCA: Akcea Therapeutics, Inc. - Zacks Investment Research AKCA: Akcea Therapeutics, Inc. - Earnings Announcements. Stay up to date with lastest Earnings Announcements for Akcea Therapeutics, Inc. from Zacks Investment Research
NOTE: The Closing Price, Day's High, Day's Low, and Day's Volume have been adjusted to account for any stock splits and/or dividends which may have occurred for this security since the date shown above.
Stock Information | Akcea Therapeutics NOTE: The Closing Price, Day's High, Day's Low, and Day's Volume have been adjusted to account for any stock splits and/or dividends which may have occurred for this security since the date shown above. AKCA Stock Price, Forecast & News (Akcea Therapeutics) 4 equities research analysts have issued 1 year price objectives for Akcea Therapeutics' stock. Their forecasts range from $24.00 to $41.00. On average, they expect Akcea Therapeutics' stock price to reach $34.67 in the next year. This suggests a possible upside of 142.4% from the stock's current price.
27 Feb 2020 As you might know, Akcea Therapeutics, Inc. (NASDAQ:AKCA) just kicked off its latest full-year results with some very
Find real-time AKCA - Akcea Therapeutics Inc stock quotes, company profile, news and forecasts from CNN Business. AKCA | Stock Snapshot - Fidelity Apr 01, 2020 · Akcea Therapeutics, Inc., a biopharmaceutical company, focuses on developing and commercializing drugs to treat patients with serious and rare diseases in the United States and internationally. The company offers TEGSEDI, which is designed to …
Akcea Therapeutics, Inc. - AKCA - Stock Price & News | The ...
Akcea Therapeutics, Inc. engages in the development and marketing of drugs globally to treat patients with rare and serious diseases using antisense Researching Akcea Therapeutics (NASDAQ:AKCA) stock? View AKCA's stock price, price target, earnings, financials, forecast, insider trades, news, and SEC Akcea Therapeutics Inc is a commercial-stage biopharmaceutical company focused on developing and commercializing drugs to treat patients with serious
Akcea Stocks Soars on Pfizer Licensing Agreement - TheStreet
View Akcea Therapeutics, Inc. AKCA investment & stock information. Get the latest Akcea Therapeutics, Inc. AKCA detailed stock quotes, stock data, Real-Time ECN, charts, stats and more.
Akcea Therapeutics Learn about Akcea’s core values and hear from Akcea Canada’s Vice President & GM, Jared Rhines. Akcea Therapeutics Inc Stock Technical Analysis (AKCA ... A brief summary - strong Buy, Buy, strong Sell, Sell or Neutral signals for the Akcea Therapeutics Inc stock. A detailed technical analysis through moving averages buy/sell signals (simple and